查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美側向層析檢測市場預測至 2030 年 - 區域分析 - 按產品類型、技術、測試類型、應用和最終用戶
市場調查報告書
商品編碼
1510734

北美側向層析檢測市場預測至 2030 年 - 區域分析 - 按產品類型、技術、測試類型、應用和最終用戶

North America Lateral Flow Assay Market Forecast to 2030 - Regional Analysis - by Product Type, Technique, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 132 Pages | 訂單完成後即時交付

價格

2022年北美側流檢測市值為36.8712億美元，預計2030年將達到70.8953億美元；預計2022年至2030年複合年成長率為8.5%。

擴大使用家庭檢測試劑盒推動了北美側向層析檢測市場

側向層析測定 (LFA) 是紙本測試，旨在檢測複雜混合物（生物樣品）中的分析物（條件特異性生物分子），其中樣品放置在測試設備中的指定位置。這些測試會在 5-30 分鐘內提供結果。側流檢測試劑盒在各種環境條件下均表現出穩定性，並具有較長的保存期限。基於後來的流式檢測的家庭測試允許用戶測試自行收集的樣本並獲得結果，而無需經過培訓的醫療專業人員的幫助。這些測試通常在櫃檯出售。妊娠檢測試劑盒是家庭側流檢測最常見的例子之一。此外，這些檢測方法旨在診斷傳染病、心血管疾病和愛滋病毒等恥辱性疾病。因此，這些疾病的盛行率不斷上升，以及家庭醫療保健中擴大採用側流檢測，推動了側流檢測市場的成長。在 COVID-19 大流行期間，由於人們不願意去醫院或診斷實驗室進行檢測，許多公司引入了家用側向層析檢測來診斷 SARS-CoV-2 感染。

2020年10月，西門子醫療推出了CLINITEST快速COVID-19抗原自檢，有助於在15分鐘內檢測出感染情況，以便更快地隔離感染者，避免疾病傳播。

2020 年 7 月，BD 推出了攜帶式快速照護端抗原測試，可在 15 分鐘內檢測 SARS-CoV-2 感染。

2020 年 8 月，美國食品藥物管理局 (FDA) 頒發了 Abbott BinaxNOW COVID-19 Ag 卡的緊急使用授權，這是一種檢測該疾病的快速檢測方法。 BinaxNOW 使用 Abbott 成熟的側向層析技術，使其成為醫療保健提供者之間進行頻繁大規模檢測的友好且可靠的方法。

2020 年 9 月，羅氏針對接受 CE 標誌的市場推出了 SARS-CoV-2 快速抗原測試。

北美側向層析檢測市場概況

北美側流檢測市場分為美國、加拿大和墨西哥。 2022 年，美國佔據北美最大的側流檢測市場佔有率。 。此外，診斷行業的技術進步可能成為未來幾年北美側流檢測市場的主要驅動力。

美國側流檢測市場在北美佔有重要佔有率。美國側流檢測市場的成長歸因於對家用妊娠檢測試劑盒的需求不斷成長，以及愛滋病毒、肝炎、幽門螺旋桿菌和 COVID-19 等傳染病發病率的迅速增加。據華盛頓大學醫學院稱，每年約有 2000 萬美國女性依賴家庭妊娠檢測，這促進了基於側流檢測的妊娠檢測試劑盒的採用。

北美側向層析檢測市場收入及 2030 年預測（百萬美元）

北美側向層析檢測市場區隔

北美側流分析市場按產品類型、技術、測試類型、應用、最終用戶和國家分類。

根據產品類型，北美側流檢測市場分為試劑盒和試劑以及側流讀取器。到 2022 年，試劑盒和試劑細分市場將佔據更大的北美側流檢測市場。

就技術而言，北美側流分析市場分為夾心分析、競爭分析和多重檢測分析。 2022 年，夾心檢測領域佔據北美最大的側流檢測市場。

依測試類型，北美側流檢測市場分為側流免疫檢測和核酸側流檢測。 2022 年，側流免疫分析領域將佔據更大的北美側流分析市場。

根據應用，北美側流檢測市場分為臨床測試、獸醫診斷、食品安全和環境測試以及藥物開發和品質測試。 2022 年，臨床測試領域佔據北美最大的側流檢測市場。

按最終用戶分類，北美側流檢測市場分為醫院和診所、診斷實驗室、家庭護理、獸醫診所、製藥和生物技術公司等。 2022 年，醫院和診所細分市場佔據北美最大的側流檢測市場。

按國家/地區分類，北美側流檢測市場分為美國、加拿大和墨西哥。 2022 年，美國在北美側流檢測市場佔有率中佔據主導地位。

F. Hoffmann-La Roche Ltd、Siemens Healthineers AG、Becton Dickinson and Co、PerkinElmer Inc、Hologic Inc、QIAGEN NV、bioMerieux SA、QuidelOrtho Corp、Abbott Laboratories、Merck KGaA、Bio-Rad Laboratories Inc 和 Thermo Fisher Inc.在北美側流分析市場中營運的領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美側向層析檢測市場 - 主要產業動態

  • 北美側向層析檢測市場 - 主要產業動態
  • 市場促進因素
    • 越來越多使用家庭檢測試劑盒
    • 即時檢測日益普及
  • 市場限制
    • 由於程序限制導致檢測結果不一致
  • 市場機會
    • 側向層析檢測應用的不斷發展
  • 未來的趨勢
    • 側流免疫分析中的智慧型手機使用和人工智慧整合
  • 影響分析

第 5 章：側流分析市場 - 北美市場分析

  • 北美側向層析檢測市場收入，2020 - 2030

第 6 章：北美側向層析檢測市場分析 - 產品類型

  • 試劑盒和試劑
    • 概述
    • 試劑盒和試劑：北美側向層析檢測市場、收入和 2030 年預測
  • 側向層析閱讀器
    • 概述
    • 側流層析讀者：北美側流層析檢測市場、收入與 2030 年預測

第 7 章：北美側向層析檢測市場分析 - 技術

  • 夾心試驗
    • 概述
    • 三明治檢測：北美側流檢測市場、收入與 2030 年預測
  • 競爭性分析
    • 概述
    • 競爭分析：北美側流分析市場、收入與 2030 年預測
  • 多重檢測分析
    • 概述
    • 多重檢測分析：北美側流分析市場、收入與 2030 年預測

第 8 章：北美側向層析檢測市場分析 - 測試類型

  • 側流免疫分析
    • 概述
    • 側流免疫分析：北美側流分析市場、收入與 2030 年預測
  • 核酸側流層析檢測
    • 概述
    • 核酸側流分析：北美側流分析市場、收入與 2030 年預測

第 9 章：北美側流分析市場分析 - 應用

  • 臨床測試
    • 概述
    • 臨床測試：北美側向層析檢測市場、收入和 2030 年預測
  • 獸醫診斷
    • 概述
    • 獸醫診斷：北美側向層析檢測市場、收入和 2030 年預測
  • 食品安全與環境檢測
    • 概述
    • 食品安全與環境檢測：北美側流檢測市場、收入與 2030 年預測
  • 藥物開發和品質測試
    • 概述
    • 藥物開發與品質測試：北美側向層析檢測市場、收入與 2030 年預測

第 10 章：北美側流偵測市場分析 - 最終用戶

  • 醫院和診所
    • 概述
    • 醫院和診所：北美側向層析檢測市場、收入和 2030 年預測
  • 診斷實驗室
    • 概述
    • 診斷實驗室：北美側向層析檢測市場、收入和 2030 年預測
  • 居家護理
    • 概述
    • 家庭護理：北美側向層析檢測市場、收入和 2030 年預測
  • 獸醫診所
    • 概述
    • 獸醫診所：北美側向層析檢測市場、收入和 2030 年預測
  • 製藥與生物技術公司
    • 概述
    • 製藥和生物技術公司：北美側向層析檢測市場、收入和 2030 年預測
  • 其他
    • 概述
    • 其他：北美側向層析檢測市場、收入和 2030 年預測

第 11 章：北美側向層析檢測市場 - 國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 12 章：產業格局

  • 概述
  • 側流分析市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Becton Dickinson and Co
  • PerkinElmer Inc
  • Hologic Inc
  • QIAGEN NV
  • bioMerieux SA
  • QuidelOrtho Corp
  • Abbott Laboratories
  • Merck KGaA
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc

第 14 章：附錄

Product Code: BMIRE00028829

The North America lateral flow assay market was valued at US$ 3,687.12 million in 2022 and is expected to reach US$ 7,089.53 million by 2030; it is estimated to register a CAGR of 8.5% from 2022 to 2030.

Increasing Use of Home-Based Assay Kits Fuels North America Lateral Flow Assay Market

Lateral flow assays (LFA) are paper-based tests designed for the detection of analytes (condition-specific biomolecules) in complex mixtures (biological samples), wherein samples are placed in a designated spot in a test device. These tests provide results within 5-30 minutes. Lateral flow assay kits exhibit stability over various environmental conditions and prolonged shelf life. Home tests based on later flow assays permit users to test self-collected samples and get results without the assistance of a trained medical professional. These tests are generally sold over the counter. A pregnancy test kit is one of the most familiar examples of home-based lateral flow assays. Further, these assays are designed for the diagnosis of infectious diseases, cardiovascular diseases, and stigmatized diseases such as HIV. Therefore, the rising prevalence of these diseases and the increasing adoption of lateral flow assay testing in home healthcare drive the lateral flow assay market growth. During the COVID-19 pandemic, many companies introduced at-home lateral flow assays for the diagnosis of SARS-CoV-2 infection due to people's reluctance to visit hospitals or diagnostic labs for testing.

In October 2020, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen Self-Test that helps detect the infection in 15 minutes so that the infected individuals can be isolated sooner to avoid the disease spread.

In July 2020, BD Launched a portable, rapid point-of-care antigen test to detect SARS-CoV-2 infection in 15 minutes.

In August 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization for Abbott BinaxNOW COVID-19 Ag Card, a rapid test to detect the disease. BinaxNOW uses Abbott's proven lateral flow technology, making it a friendly and reliable method for frequent mass testing among healthcare providers.

In September 2020, Roche launched a SARS-CoV-2 Rapid Antigen Test for markets accepting the CE Mark.

North America Lateral Flow Assay Market Overview

North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US held the largest North America lateral flow assay market share in 2022. The market growth in the region is characterized by the growing prevalence of various diseases, government support for advanced diagnostics adoption, and increasing efforts in R&D and other activities undertaken by market players. In addition, technological advancements in the diagnosis industry are likely to be a major driver for the North America lateral flow assay market over the coming years.

The US lateral flow assay market holds a significant share in North America. The growth of the US lateral flow assay market is attributed to the growing demand for at-home kits for pregnancy testing and the rapidly increasing incidence of infectious diseases, such as HIV, Hepatitis, H. pylori, and COVID-19. According to the Washington University School of Medicine, annually, ~20 million women in the US rely on home pregnancy tests, which boosts the adoption of lateral flow assay-based pregnancy test kits.

North America Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)

North America Lateral Flow Assay Market Segmentation

The North America lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.

Based on product type, the North America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger North America lateral flow assay market share in 2022.

In terms of technique, the North America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest North America lateral flow assay market share in 2022.

By test type, the North America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger North America lateral flow assay market share in 2022.

Based on application, the North America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest North America lateral flow assay market share in 2022.

By end user, the North America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest North America lateral flow assay market share in 2022.

By country, the North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US dominated the North America lateral flow assay market share in 2022.

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America lateral flow assay market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Lateral Flow Assay Market - Key Industry Dynamics

  • 4.1 North America Lateral Flow Assay Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Use of Home-Based Assay Kits
    • 4.2.2 Rising Popularity of Point-of-Care Testing
  • 4.3 Market Restraints
    • 4.3.1 Inconsistent Assay Results Due to Procedural Limitations
  • 4.4 Market Opportunities
    • 4.4.1 Evolving Applications of Lateral Flow Assays
  • 4.5 Future Trends
    • 4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
  • 4.6 Impact analysis

5. Lateral Flow Assay Market - North America Market Analysis

  • 5.1 North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030

6. North America Lateral Flow Assay Market Analysis - Product Type

  • 6.1 Kits & Reagents
    • 6.1.1 Overview
    • 6.1.2 Kits & Reagents: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Lateral Flow Readers
    • 6.2.1 Overview
    • 6.2.2 Lateral Flow Readers: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Lateral Flow Assay Market Analysis - Technique

  • 7.1 Sandwich Assay
    • 7.1.1 Overview
    • 7.1.2 Sandwich Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Competitive Assays
    • 7.2.1 Overview
    • 7.2.2 Competitive Assays: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Multiplex Detection Assay
    • 7.3.1 Overview
    • 7.3.2 Multiplex Detection Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Lateral Flow Assay Market Analysis - Test Type

  • 8.1 Lateral Flow Immunoassay
    • 8.1.1 Overview
    • 8.1.2 Lateral Flow Immunoassay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Nucleic Acid Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Lateral Flow Assay Market Analysis - Application

  • 9.1 Clinical Testing
    • 9.1.1 Overview
    • 9.1.2 Clinical Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Veterinary Diagnostics
    • 9.2.1 Overview
    • 9.2.2 Veterinary Diagnostics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Food Safety & Environment Testing
    • 9.3.1 Overview
    • 9.3.2 Food Safety & Environment Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Drug Development & Quality Testing
    • 9.4.1 Overview
    • 9.4.2 Drug Development & Quality Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

10. North America Lateral Flow Assay Market Analysis - End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Diagnostics Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostics Laboratories: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Homecare
    • 10.3.1 Overview
    • 10.3.2 Homecare: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Veterinary Clinics
    • 10.4.1 Overview
    • 10.4.2 Veterinary Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Pharmaceutical & Biotechnology Companies
    • 10.5.1 Overview
    • 10.5.2 Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

11. North America Lateral Flow Assay Market - Country Analysis

  • 11.1 North America Lateral Flow Assay Market, Revenue and Forecast To 2030
    • 11.1.1 North America Lateral Flow Assay Market Revenue and Forecasts and Analysis - By Country
      • 11.1.1.1 US: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.1.3 US Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 US Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.1.5 US Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.1.6 US Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.1.7 US Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Canada: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.2.3 Canada Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Canada Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.2.5 Canada Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Canada Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.2.7 Canada Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Mexico: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
        • 11.1.1.3.3 Mexico Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Mexico Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Mexico Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.1.3.6 Mexico Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.3.7 Mexico Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Lateral Flow Assay Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Siemens Healthineers AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Becton Dickinson and Co
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 PerkinElmer Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hologic Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 QIAGEN NV
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 bioMerieux SA
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 QuidelOrtho Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Abbott Laboratories
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Merck KGaA
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Thermo Fisher Scientific Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Lateral Flow Assay Market Segmentation
  • Table 2. US Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Recent Organic Growth Strategies in the Lateral Flow Assay Market
  • Table 18. Recent Inorganic Growth Strategies in the Lateral Flow Assay Market
  • Table 19. Glossary of Terms, Lateral Flow Assay Market

List Of Figures

  • Figure 1. North America Lateral Flow Assay Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030
  • Figure 4. North America Lateral Flow Assay Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 5. Kits & Reagents: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Lateral Flow Readers: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. North America Lateral Flow Assay Market Revenue Share, by Technique, 2022 & 2030 (%)
  • Figure 8. Process of Sandwich Lateral Flow Assay
  • Figure 9. Sandwich Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Process of Competitive Lateral Flow Assay
  • Figure 11. Competitive Assays: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Multiplex Detection Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. North America Lateral Flow Assay Market Revenue Share, by Test Type, 2022 & 2030 (%)
  • Figure 14. Lateral Flow Immunoassay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. North America Lateral Flow Assay Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 17. Clinical Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Veterinary Diagnostics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Food Safety & Environment Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Drug Development & Quality Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. North America Lateral Flow Assay Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals and Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Diagnostics Laboratories: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Homecare: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. Veterinary Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Others: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. North America Lateral Flow Assay Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Lateral Flow Assay Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 30. US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 31. Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 32. Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 33. Growth Strategies in the Lateral Flow Assay Market